J1448 HCPCS code: Injection, trilaciclib, 1mg
J1448 is the HCPCS Level II code for injection, trilaciclib, 1mg. In 2024 Medicare paid an average of $4.09 per service for J1448 across 2,214,683 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 900 per day on outpatient hospital claims. Medicare volume rose 39% from 2022 to 2024 (1,588,326 to 2,214,683 services). In 2024, about 576 clinicians billed Medicare for J1448 for 440 beneficiaries; Florida, Illinois, Tennessee accounted for 47% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2021-10-01 |
| Last action effective | 2021-10-01 |
Who bills J1448 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 576 |
| Medicare beneficiaries | 440 |
| States with claims | 13 |
| Share of services in top 3 states (Florida, Illinois, Tennessee) | 47% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1448, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,588,326 | 315 | $4.88 | $3.90 |
| 2023 | 1,865,135 | 351 | $5.00 | $3.99 |
| 2024 | 2,214,683 | 440 | $5.14 | $4.09 |
States with the most J1448 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 441,124 | $4.14 |
| Illinois | 226,318 | $3.87 |
| Tennessee | 194,954 | $4.14 |
| Arkansas | 192,300 | $4.10 |
| Alabama | 175,965 | $4.13 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 900 | CMS Policy |
| practitioner claims | 900 | CMS Policy |
What changed for J1448
- 2021-10-01: J1448 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1448?
J1448 is the HCPCS Level II code for injection, trilaciclib, 1mg. Short descriptor: "Injection, trilaciclib, 1mg".
How much does Medicare pay for J1448?
In 2024, the average Medicare payment was $4.09 per service (average allowed $5.14).
Does Medicare cover J1448?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1448 can be billed per day?
900 on outpatient hospital claims; 900 on practitioner claims (NCCI medically unlikely edits).
Related J14 codes
- J1410 — Injection, estrogen conjugated, per 25 mg
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426 — Injection, casimersen, 10 mg
- J1427 — Injection, viltolarsen, 10 mg
- J1428 — Injection, eteplirsen, 10 mg
- J1429 — Injection, golodirsen, 10 mg
- J1430 — Injection, ethanolamine oleate, 100 mg
- J1434 — Injection, fosaprepitant (focinvez), 1 mg
- J1435 — Injection, estrone, per 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1448
- Watch J1448 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1448
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.